Cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cysteine cathepsins in cells and tissues of stefin B-deficient mice

Biological Chemistry

Volumn 388, Issue 8, 2007, Pages 847-852

  Kopitar Jerala, Nataša ^a   Turk, Boris ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cathepsin; Inhibitor; MARCKS; Progressive myoclonus epilepsy

Indexed keywords

CALPAIN; CATHEPSIN B; CELL EXTRACT; CYSTATIN B; CYSTEINE; CYSTEINE PROTEINASE; MARCKS PROTEIN; STEFIN B; TISSUE EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; ENZYME MECHANISM; KIDNEY; LIVER; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION;

ANIMALS; CATHEPSINS; CYSTATINS; CYSTEINE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGAN SPECIFICITY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; TISSUE EXTRACTS;

MUS;

EID: 34547497862     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.092     Document Type: Article

References (37)

1. Aderem, A. (1992). Signal transduction and the actin cytoskeleton: the roles of MARCKS and profilin. Trends Biochem. Sci. 17, 438-443.
2. Allen, L.A. and Aderem, A. (1995). Protein kinase C regulates MARCKS cycling between plasma membrane and lysosomes in fibroblasts. EMBO J. 14, 1109-1120.
3. Arbuzova, A., Schmitz, A.A., and Vergeres, G. (2002) Cross-talk unfolded: MARCKS proteins. Biochem. J. 362, 1-12.
4. Blackshear, P.J. (1993). The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 268, 1501-1504.
5. Brannvall, K., Hjelm, H., Korhonen, L., Lahtinen, U., Lehesjoki, A.E., and Lindholm, D. (2003). Cystatin-B is expressed by neural stem cells and by differentiated neurons and astrocytes. Biochem. Biophys. Res. Commun. 308, 369-374.
6. Braun, T., McIlhinney, R.A., and Vergeres, G. (2000). Myristoylation-dependent N-terminal cleavage of the myristoylated alanine-rich C kinase substrate (MARCKS) by cellular extracts. Biochimie 82, 705-715.
7. Carballo, E., Pitterle, D.M., Stumpo, D.J., Sperling, R.T., and Blackshear, P.J. (1999). Phagocytic and macropinocytic activity in MARCKS-deficient macrophages and fibroblasts. Am. J. Physiol. 277, C163-C173.
8. Cirman, T., Oresic, K., Mazovec, G.D., Turk, V., Reed, J.C., Myers, R.M., Salvesen, G.S., and Turk, B. (2003). Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 279, 3578-3587.
9. Cuervo, A.M. (2004). Autophagy: many paths to the same end. Mol. Cell Biochem. 263, 55-72.
10. Di Giaimo, R., Riccio, M., Santi, S., Galeotti, C., Ambrosetti, D.C., and Melli, M. (2002). New insights into the molecular basis of progressive myoclonus epilepsy: a multiprotein complex with cystatin B. Hum. Mol. Genet. 11, 2941-2950.
11. Dulong, S., Goudenege, S., Vuillier-Devillers, K., Manenti, S., Poussard, S., and Cottin, P. (2004). Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Ca and calpain proteolytic cleavage. Biochem. J. 382, 1015-1023.
12. Goudenege, S., Poussard, S., Dulong, S., and Cottin, P. (2005). Biologically active milli-calpain associated with caveolae is involved in a spatially compartmentalised signalling involving protein kinase Cα and myristoylated alanine-rich C-kinase substrate (MARCKS). Int. J. Biochem. Cell Biol. 37, 1900-1910.
13. Hartwig, J.H., Thelen, M., Rosen, A., Janmey, P.A., Nairn, A.C., and Aderem, A. (1992). MARCKS is an actin filament cross-linking protein regulated by protein kinase C and calcium-calmodulin. Nature 356, 618-622.
14. Houseweart, M.K., Pennacchio, L.A., Vilaythong, A., Peters, C., Noebels, J.L., and Myers, R.M. (2003). Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J. Neurobiol. 56, 315-327.
15. Kinne, R., Saukko, P., Jarvinen, M., and Lehesjoki, A.E. (2002). Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy. Ann. Med. 34, 380-385.
16. Kopitar-Jerala, N., Schweiger, A., Myers, R.M., Turk, V., and Turk, B. (2005). Sensitization of stefin B-deficient thymocytes towards staurosporin-induced apoptosis is independent of cysteine cathepsins. FEBS Lett. 579, 2149-2155.
17. Lalioti, M.D., Mirotsou, M., Buresi, C., Peitsch, M.C., Rossier, C., Ouazzani, R., Baldy-Moulinier, M., Bottani, A., Malafosse, A., and Antonarakis, S.E. (1997a). Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1). Am. J. Hum. Genet. 60, 342-351.
18. Lalioti, M.D., Scott, H.S., Buresi, C., Rossier, C., Bottani, A., Morris, M.A., Malafosse, A., and Antonarakis, S.E. (1997b). Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386, 847-851.
19. Laumas, S., Abdel-Ghany, M., Leister, K., Resnick, R., Kandrach, A., and Racker, E. (1989). Decreased susceptibility of a 70-kDa protein to cathepsin L after phosphorylation by protein kinase C. Proc. Natl. Acad. Sci. USA 86, 3021-3025.
20. Levine, B. and Klionsky, D.J. (2004). Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6, 463-477.
21. Lieuallen, K., Pennacchio, L.A., Park, M., Myers, R.M., and Lennon, G.G. (2001). Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes. Hum. Mol. Genet. 10, 1867-1871.
22. Manenti, S., Taniguchi, H., Sorokine, O., Van Dorsselaer, A., and Darbon, J.M. (1997). Specific proteolytic cleavage of the myristoylated alanine-rich C kinase substrate between Asn 147 and Glu 148 also occurs in brain. J. Neurosci. Res. 48, 259-263.
23. McLaughlin, S. and Aderem, A. (1995). The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. Trends Biochem. Sci. 20, 272-276.
24. Ohmori, S., Sakai, N., Shirai, Y., Yamamoto, H., Miyamoto, E., Shimizu, N., and Saito, N. (2000). Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoylated alanine-rich C-kinase substrate. J. Biol. Chem. 275, 26449-26457.
25. Pennacchio, L.A., Bouley, D.M., Higgins, K.M., Scott, M.P., Noebels, J.L., and Myers, R.M. (1998). Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat. Genet. 20, 251-258.
26. Pennacchio, L.A., Lehesjoki, A.E., Stone, N.E., Willour, V.L., Virtaneva, K., Miao, J., D'Amato, E., Ramirez, L., Faham, M., Koskiniemi, M., et al. (1996). Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731-1734.
27. Quraishi, O. and Storer, A.C. (2001). Identification of internal autoproteolytic cleavage sites within the prosegments of recombinant procathepsin B and procathepsin S. Contribution of a plausible unimolecular autoproteolytic event for the processing of zymogens belonging to the papain family. J. Biol. Chem. 276, 8118-8124.
28. Riccio, M., Di Giaimo, R., Pianetti, S., Palmieri, P.P., Melli, M., and Santi, S. (2001). Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1). Exp. Cell Res. 262, 84-94.
29. Rozman-Pungercar, J., Kopitar-Jerala, N., Bogyo, M., Turk, D., Vasiljeva, O., Stefe, I., Vandenabeele, P., Bromme, D., Puizdar, V., Fonovic, M., et al. (2003). Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 10, 881-888.
30. Spizz, G. and Blackshear, P.J. (1996). Protein kinase C-mediated phosphorylation of the myristoylated alanine-rich C-kinase substrate protects it from specific proteolytic cleavage. J. Biol. Chem. 271, 553-562.
31. Spizz, G. and Blackshear, P.J. (1997). Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J. Biol. Chem. 272, 23833-23842.
32. Stoka, V., Turk, B., Schendel, S.L., Kim, T.H., Cirman, T., Snipas, S.J., Ellerby, L.M., Bredesen, D., Freeze, H., Abrahamson, M., et al. (2001). Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J. Biol. Chem. 276, 3149-3157.
33. Stumpo, D.J., Graff, J.M., Albert, K.A., Greengard, P., and Blackshear, P.J. (1989). Molecular cloning, characterization, and expression of a cDNA encoding the '80- to 87-kDa' myristoylated alanine-rich C kinase substrate: a major cellular substrate for protein kinase C. Proc. Natl. Acad. Sci. USA 86, 4012-4016.
34. Stumpo, D.J., Bock, C.B., Tuttle, J.S., and Blackshear, P.J. (1995). MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc. Natl. Acad. Sci. USA 92, 944-948.
35. Thelen, M., Rosen, A., Nairn, A.C., and Aderem, A. (1991). Regulation by phosphorylation of reversible association of amyristoylated protein kinase C substrate with the plasma membrane. Nature 351, 320-322.
36. Turk, B., Turk, V., and Turk, D. (1997). Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378, 141-150.
37. Wang, J., Gambhir, A., Hangyas-Mihalyne, G., Murray, D., Golebiewska, U., and McLaughlin, S. (2002). Lateral sequestration of phosphatidylinositol 4,5-bisphosphate by the basic effector domain of myristoylated alanine-rich C kinase substrate is due to nonspecific electrostatic interactions. J. Biol. Chem. 277, 34401-34412.